Yosuke Taruno

Impact of Gba2 on neuronopathic Gaucher’s disease and α-synuclein accumulation in medaka (Oryzias latipes)

R. Takahashi, S. Matsuzawa, M. Kinoshita, 2021, Molecular Brain.

ATP13A2 deficiency induces a decrease in cathepsin D activity, fingerprint‐like inclusion body formation, and selective degeneration of dopaminergic neurons

Y. Sakaki, A. Toyoda, N. Hattori, 2013, FEBS letters.

Motor Progression and Nigrostriatal Neurodegeneration in Parkinson Disease

N. Sawamoto, Y. Fushimi, Y. Nakamoto, 2022, Annals of neurology.

Impact of the catechol-O-methyltransferase Val158Met polymorphism on the pharmacokinetics of l-dopa and its metabolite 3-O-methyldopa in combination with entacapone

N. Sawamoto, Shota Yamamoto, R. Takahashi, 2020, Journal of Neural Transmission.

Idiopathic rapid eye movement sleep behavior disorder in Japan: An observational study.

H. Iwaki, T. Hanakawa, Y. Shimo, 2022, Parkinsonism & related disorders.

Perampanel Inhibits α‐Synuclein Transmission in Parkinson's Disease Models

R. Takahashi, S. Matsuzawa, N. Uemura, 2021, Movement disorders : official journal of the Movement Disorder Society.

Repurposing bromocriptine for Aβ metabolism in Alzheimer’s disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer’s disease with presenilin 1 (PSEN1) mutations

K. Ishii, Y. Sunada, R. Takahashi, 2021, BMJ Open.

[Glutamic acid decarboxylase].

R. Matsumoto, T. Yunoki, Yudai Takatani, 1962, Ukrains'kyi biokhimichnyi zhurnal.